ArticlePloS one2026
A Lipoxygenase 3 mutation reverses growth phenotypes in an Arabidopsis Plastid Lipase 3 overexpression line.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Increased Temperatures Promote Fruit Enlargement Through Cellular and Transcriptomic Changes in Raspberries (Plants (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plastid Lipase 3 (PLIP3) is a chloroplast phospholipase A that cleaves linolenic acid, a polyunsaturated fatty acid, from the sn-1 position of the chloroplast membrane lipid monogalactosyldiacylglycerol. Linolenic acid is subsequently converted by enzymes in the chloroplast and the peroxisome to jasmonic acid (JA) requiring transport between the organelles. Overexpression of a cDNA encoding PLIP3 resulted in stunted plant growth with altered leaf morphology caused by accumulation of JA and other oxylipin metabolites redirecting the metabolism from growth to defense. We conducted a genetic suppressor screen in the PLIP3-OX (PLIP3 overexpression) line to query the entire pathway from the start of JA biosynthesis to its perception, transduction, and modification by other signaling pathways. We identified a mutant allele of the 13-lipoxgenase LOX3, lox3-4, that is causal to the attenuation of the PLIP3-OX phenotype with reduced dwarfism and decreased production of JA and other oxylipins. The responsible G776E point mutation is in the C terminal catalytic domain in proximity to the non heme iron binding site of LOX3. The point mutation likely inhibits the oxidation of α-linolenic acid demonstrating its importance for general JA biosynthesis as its activity cannot be compensated for by other 13-lipoxygenases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.